报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 67.61% | -17.05% | -2.98% | 37/128 | 53.28% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 69.68% | -16.2% | -2.69% | 31/128 | 53.52% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 71.61% | -13.89% | -5.78% | 27/128 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 76.01% | -10.32% | -6.75% | 12/128 | 53.72% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 81.51% | -4.57% | -1.98% | 6/128 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 83.15% | -2.44% | -0.01% | 5/128 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 83.16% | -2.31% | -1.89% | 5/128 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 84.75% | 0.55% | -0.77% | 4/128 | 53.93% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 85.41% | 1.7% | 0.2% | 4/128 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 85.23% | 1.71% | 0.14% | 5/128 | 54.68% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 85.12% | 2.45% | 0.98% | 4/128 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 84.29% | 0.45% | 0.36% | 8/128 | 57.3% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 83.98% | -0.95% | 0.22% | 7/128 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 83.8% | -1.96% | 0.87% | 8/128 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 83.08% | -2.4% | -0.98% | 8/128 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 83.91% | -2.07% | -1.03% | 8/128 | 59.64% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 84.79% | 2% | -0.81% | 7/128 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 85.48% | -0.76% | 0.41% | 8/128 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2020-03-31 | 85.13% | 2% | -0.65% | 8/128 | 58.33% | 正海生物 | 94.38% | 行业排名> |
2019-12-31 | 85.69% | 5.3% | -0.52% | 7/128 | 56.28% | 正海生物 | 93.12% | 行业排名> |
2019-06-30 | 86.13% | 2% | 5.85% | 5/128 | 57.37% | 正海生物 | 93.78% | 行业排名> |
2018-12-31 | 81.37% | 8.33% | 8.33% | 13/128 | 55.53% | 正海生物 | 93.09% | 行业排名> |
2017-12-31 | 75.11% | 5% | 5% | 20/128 | 55.34% | 正海生物 | 93.85% | 行业排名> |
2016-12-31 | 71.54% | 2% | 2% | 26/128 | 56.43% | 正海生物 | 93.08% | 行业排名> |